MOSPD1 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Clozapine inhibits MOSPD1 by binding to its active site, thus blocking the enzyme's function in promoting cell migration and invasion. It may disrupt intracellular signaling pathways related to MOSPD1, leading to reduced cancer metastasis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB-203580 inhibits MOSPD1 by inhibiting its activation and subsequent downstream signaling, which can help reduce inflammation and immune cell migration by disrupting MOSPD1's involvement in these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that indirectly affects MOSPD1 by blocking the PI3K pathway. This, in turn, reduces the activation of MOSPD1 and its role in cell migration and adhesion. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits MOSPD1 by interfering with the mTOR pathway, which regulates MOSPD1 activation. Inhibition of mTOR reduces MOSPD1-mediated processes like cell motility and metastasis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits MOSPD1 by blocking the JNK pathway, which is involved in MOSPD1 activation. This inhibition can lead to decreased cell migration and invasion, particularly in cancer cells. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor that indirectly affects MOSPD1 by disrupting PI3K-mediated signaling pathways. This leads to reduced activation of MOSPD1 and its role in cell migration and adhesion. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MOSPD1 by targeting the MEK pathway, a downstream signaling cascade of MOSPD1. Blocking MEK activation helps reduce MOSPD1-mediated cell migration and invasion. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB-431542 is a TGF-beta receptor inhibitor that indirectly affects MOSPD1 by blocking TGF-beta signaling. Inhibition of TGF-beta can reduce MOSPD1-mediated processes like cell motility and metastasis. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
SB-505124 inhibits MOSPD1 by targeting the ALK4/5/7 receptor kinases involved in the TGF-beta pathway. This inhibition can lead to decreased MOSPD1-mediated cell migration and invasion. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
SP2509 is a specific inhibitor of MOSPD1 that directly binds to the enzyme's active site. It disrupts MOSPD1's function, inhibiting cell migration and invasion, making it a potential anti-cancer agent. | ||||||